Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department
- PMID: 32227490
- PMCID: PMC7228409
- DOI: 10.1002/jmv.25800
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department
Conflict of interest statement
As widely documented to the Editor of the Journal of Medical Virology, I and my collaborators don't have any conflict of interest. On March 25, 2020, after submission of this manuscript, Foundation IRCCS Policlinico San Matteo signed a research contract with DiaSorin on different projects: i) validation of a rapid assay for detection of SARS CoV2 RNA and ii) validation of an automated CLIA assay for detection of SARS CoV2 neutralizing antibodies. The authors don t have any economical or any other forms of conflict of interest.
References
-
- WHO . Novel coronavirus—China. Accessed 19 January 2020. http://wwwwhoint/csr/don/12‐january‐2020‐novel‐coronavirus‐china/en/
-
- Binnicker MJ. Emergence of a novel coronavirus disease (COVID‐19) and the importance of diagnostic testing: why partnership between clinical laboratories, public health agencies, and industry is essential to control the outbreak [published online ahead of print March 12, 2020]. Clin Chem. 10.1093/clinchem/hvaa071 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
